Henry Schein, Inc. (NASDAQ:HSIC) Holdings Cut by M&R Capital Management Inc.

M&R Capital Management Inc. lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.6% during the second quarter, Holdings Channel reports. The firm owned 11,337 shares of the company’s stock after selling 180 shares during the period. M&R Capital Management Inc.’s holdings in Henry Schein were worth $919,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of HSIC. Cambridge Investment Research Advisors Inc. grew its position in Henry Schein by 2.4% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 5,262 shares of the company’s stock worth $459,000 after purchasing an additional 122 shares during the last quarter. HB Wealth Management LLC grew its position in Henry Schein by 0.8% in the 1st quarter. HB Wealth Management LLC now owns 15,822 shares of the company’s stock worth $1,290,000 after purchasing an additional 123 shares during the last quarter. ETF Managers Group LLC grew its position in Henry Schein by 1.5% in the 1st quarter. ETF Managers Group LLC now owns 8,278 shares of the company’s stock worth $675,000 after purchasing an additional 123 shares during the last quarter. Johnson Financial Group Inc. grew its position in Henry Schein by 2.0% in the 4th quarter. Johnson Financial Group Inc. now owns 7,515 shares of the company’s stock worth $600,000 after purchasing an additional 145 shares during the last quarter. Finally, Studio Investment Management LLC grew its position in Henry Schein by 3.9% in the 4th quarter. Studio Investment Management LLC now owns 4,160 shares of the company’s stock worth $332,000 after purchasing an additional 155 shares during the last quarter. Institutional investors own 93.31% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.71 during trading on Thursday, reaching $73.92. The company had a trading volume of 83,387 shares, compared to its average volume of 854,087. Henry Schein, Inc. has a 52 week low of $64.75 and a 52 week high of $89.72. The stock has a market cap of $9.65 billion, a PE ratio of 21.53, a PEG ratio of 2.06 and a beta of 0.83. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.91 and a current ratio of 1.72. The business’s 50 day moving average price is $77.65 and its 200-day moving average price is $78.46.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, August 7th. The company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.03. Henry Schein had a net margin of 3.64% and a return on equity of 15.76%. The company had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.13 billion. During the same period in the previous year, the firm posted $1.16 earnings per share. The company’s revenue was up 2.3% on a year-over-year basis. Analysts expect that Henry Schein, Inc. will post 5.27 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have recently weighed in on HSIC shares. JPMorgan Chase & Co. lifted their target price on shares of Henry Schein from $80.00 to $83.00 and gave the company a “neutral” rating in a research report on Wednesday, August 9th. StockNews.com assumed coverage on shares of Henry Schein in a research report on Thursday, August 17th. They set a “buy” rating on the stock. Bank of America reduced their price target on shares of Henry Schein from $76.00 to $75.00 in a research report on Monday, August 7th. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a research report on Tuesday, August 8th. Finally, Stifel Nicolaus reduced their price target on shares of Henry Schein from $85.00 to $80.00 in a research report on Tuesday, August 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Hold” and a consensus price target of $84.00.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.